Lisa Mielniczuk
University of Ottawa(CA)
Publications by Year
Research Areas
Cardiovascular Function and Risk Factors, Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management, Cardiac Imaging and Diagnostics, Transplantation: Methods and Outcomes
Most-Cited Works
- → Frequency of Peripartum Cardiomyopathy(2006)291 cited
- → CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction(2021)285 cited
- → Allograft Vasculopathy(2016)270 cited
- → The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review(2006)142 cited
- → Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction(2016)137 cited
- → Design of the Effect of Adaptive Servo-Ventilation on Survival and Cardiovascular Hospital Admissions in Patients with Heart Failure and Sleep Apnoea: The ADVENT-HF Trial(2017)121 cited
- → CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis(2020)120 cited
- → Prognostic Value of Rubidium-82 Positron Emission Tomography in Patients After Heart Transplant(2014)117 cited
- Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.(2017)
- → Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis(2020)111 cited